GBA Group is expanding its range of toxicology services for customers in the chemical, medical device and pharmaceutical industries with the acquisition of ICCR-Roßdorf GmbH (ICCR-Roßdorf). This acquisition underlines GBA Group's ambition to position itself broadly as an international life science service provider through targeted portfolio expansions and investment in leading CROs.

After two years it is finally time again: from 07. - 11.10.2023 the food and beverage exhibition Anuga, will take place in Cologne.

This time under the guiding theme "Sustainable Growth" to exchange ideas about meat substitutes, superfoods, sustainable production and many other trend topics. Anuga is considered the world's largest trade fair for the food and nutrition industry and combines a total of 10 trade fairs covering a wide range of topics in the food industry.

"Global efforts in the area of health care will continue to grow in the future. With this in mind, GBA Group has significantly expanded its Pharma & Medical Devices portfolio and will continue to invest in this growth market to position itself as a professionally comprehensive and internationally positioned laboratory and service provider for the benefit of our society." Steffen Walter, CEO.

With the acquisition of the Finnish company Tampereen asbesti- ja kuitulaboratorio Oy (Taklab) by Labroc Oy (Labroc), GBA Group continues to expand its European network in the field of laboratory analysis for building pollutants.

We are pleased to announce that we can now analyze your products for the content of boswellic acids. Boswellic acids occur naturally in the resin of the frankincense tree (Boswellia serrata). Since ancient times, positive effects on the human organism have been attributed to them - they are said to have anti-inflammatory, antioxidant and analgesic effects. Today, they can be found in the form of resin powder or dry extracts in numerous food supplements.